Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Penile Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Head and Neck Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Anus Neoplasms 1Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

pembrolizumab 3lenvatinib 2Specimen Handling 2Nivolumab 2Cisplatin 2trastuzumab deruxtecan 1tivozanib 1liposomal doxorubicin 1entinostat 1dostarlimab 1bintrafusp alfa protein, human 1atezolizumab 1Therapeutic Touch 1Surveys and Questionnaires 1Radiotherapy 1Radiation 1Platinum 1Paclitaxel 1Nelfinavir 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Gemcitabine 1Doxorubicin 1Dehydroepiandrosterone 1CTLA-4 Antigen 1Bupropion 1Blood Specimen Collection 1Bevacizumab 1Axitinib 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vulvar Neoplasms × entinostat × 90 days × Clear all
NCT04708470 2026-04-06

A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
55 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡